Priliminary Pharmacognostical and Phyto-Chemical Standerdisation of Saptamrita Mishrana

Authors

  • Patel Jalpa PhD Scholar, Department of Prasutitantra & Streeroga, Institute of Teaching and Research in Ayurveda (ITRA), Jamnagar
  • Donga Shilpa Professor, Department of Prasutitantra & Streeroga, Institute of Teaching and Research in Ayurveda (ITRA), Jamnagar
  • C.R. Harisha Head, Pharmacognosy Laboratory, Institute of Teaching and Research in Ayurveda (ITRA), Jamnagar
  • V.J. Shukla Head, Pharmaceutical Chemistry Laboratory, Institute of Teaching and Research in Ayurveda (ITRA), Jamnagar

Keywords:

Artavakshaya, HPTLC, Pharmacognocy, Pharmaceutics, Saptamrita Mishrana

Abstract

“Adolescence” as the time period between 10 and 19 years of life characterized by critical physical and psychological changes leading to adulthood. Menstruation is one of the most important changes during adolescent years. Menstrual disorders are frequent among adolescent girls as they are closely coupled with the processes involved in the pubertal development of females. Among them, Artavakshaya is most common pathological phenomena that occurs the most. Due to Rasadhatu Kshaya, its respective Upadhatu Artava, probably will be less formed. Reference regarding Saptamrita Mishrana was given in Nidana Chikitsa Hastamalaka. There is no scientific evaluation has been found on this formulation till date. For evaluation of phamacognostical and physico-chemical profile of Saptamrita Mishrana has been taken in this present study. Choorna of Saptamrita Mishrana was analyzed through Pharmacognostically and also it was examined through qualitative and quantitative analysis of physicochemical parameters. High Performance Thin Layer Chromatography study (HPTLC) was also studied. Pharmacognostical evaluation of course Saptamrita Mishrana revealed the diagnostic characters like acicular Crystals, phragment of anovular vessels, Starch grains, raphides and fibers of Shatavari, Black debris of various Bhasma, which authenticates genuineness of the raw drug of Saptamrita Mishrana. Qualitative study observes that pH is 6.5, Ash value is 23.6% w/w, Loss on drying is 11.59 %, Water soluble extract is 30.51 % & Alcohol soluble extract is 16.11%, HPTLC study shows that maximum 6 spots and 2 spots were obtained when viewed under short wave ultraviolet light both (254 nm) and (366 nm) respectively.

Author Biography

  • Patel Jalpa, PhD Scholar, Department of Prasutitantra & Streeroga, Institute of Teaching and Research in Ayurveda (ITRA), Jamnagar
    Dept of PTSR, ITRA, Jamnagar

References

Ranajitray Desai, Nidana Chikitsa Hastamalak, Chaturth Khanda, fourth edition, Shree Baidhyanath, Ayurved Bhavana Limited, Naini, Ilahabad, 2018, Adhyaya 4, Panduroga-Kamla, page no 404.

World Health Organization. Programming for Adolescent Health and Development, WHO Technical Report Series No. 886. Geneva: World Health Organization; 1996

Kulkarni M, Durge PM. Reproductive health morbidities among adolescent girls: Breaking the silence. Ethno Med 2011;5:165-8.

Williams C.E., Menstrual Disorders in Adolescents: Review of Current Practice, Horm Res Paediatr 2012;78:135-143. doi: 10.1159/000342822

GHDx. Canada Health Measures Survey 2009-2011. Available online at: http://ghdx.healthdata.org/record/canada-health-measures-survey-2009-2011.

Ms. Preeti Sharma, Effectiveness of educational program on menstrual irregularities and its management through home remedies: a literature based narrative review, Mukt Shabd Journal, Volume IX, Issue VI, JUNE/2020, page 1118-1130.

Nath A, Garg S. Adolescent friendly health services in India: A need of the hour. Indian J Med Sci 2008;62:465-72.

Dr. Bramhanand Tripathi, 2006 edition, Charak Samhita viman sthana 8/122, Chaukhambha surbharti Prakashan, K37/117,Gopal Mandir Lane, Varanasi, 221001.

Pandit Hemaraja Sharma, Kashyapa Samhita, Vidyotini Hindi Commentary, Chaukhamba Sanskrit Sansthan, Varanasi, 2016, Kalpa Sthana, Shatapushpa-Shatavari Kalpa/10-13, pg-280

Stability Testing on Active Ingredients and Finished Products, Quality and Biotechnology; Medicinal Products for Human Use, In: EMEA Guidelines. Ch. 3AQ16A, Vol. 3A, 3. Guidelines, EUDRALEX, Pharmaceutics; 1988, p. 145., Available from: http://www. gmpcompliance.info/euguide.htm. [Last accessed on 2015 Jun 02].

World Health Organization, Quality Control Methods for Herbal Materials, Geneva, Switzerland: World Health Organization Publication 1998. p. 11.

Anonymous, The Ayurvedic Pharmacopoeia of India, Part 2. 1st ed., Vol. 1.,New Delhi: Department of AYUSH, Ministry of Health and Family Welfare, Government of India; 2008; 140.

Agrawal BB, Prasad S, Reuter S. Identification of Novel Anti-inflammatory agents from Ayurvedic Medicine for Prevention of chronic diseases: ―Reverse pharmacology‖ and ―bedside to bench‖ approach. Cur Drug Targets, 2011; 12: 1595-653. 13

Anonymous, Quality Control Methods for Medicinal Plant Materials, Geneva: World Health Organization; 1998. 15

Gupta AK. Introduction to Pharmaceutics, 3rd ed., Vol. 1, New Delhi: CBS Publishers and Distributers; 1994. p. 270.

Agrawal BB, Prasad S, Reuter S. Identification of Novel Anti-inflammatory agents from Ayurvedic Medicine for Prevention of chronic diseases: ―Reverse pharmacology‖ and ―bedside to bench‖ approach. Curr Drug Targets, 2011; 12: 1595-653.

Downloads

Published

2022-01-13

Issue

Vol. 8 No. 3 (2021)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.